368 Counteracting TCR-T cell dysfunction in solid tumors through combination of FAS-based switch receptors and CD8-coreceptor

• Mikhail Steklov,
• Friederike Knipping,
• Paul Najm,
• Panagiota A Sotiropoulou,
• Marleen van Loenen,
• Josephine Kemna

Affiliations

Mikhail Steklov

1T-knife Therapeutics Inc., San Francisco, CA, USA

Friederike Knipping

1T-knife Therapeutics Inc., San Francisco, CA, USA

Paul Najm

2T-knife Therapeutics Inc., Berlin, Germany

Panagiota A Sotiropoulou

1T-knife Therapeutics Inc., San Francisco, CA, USA

Marleen van Loenen

1T-knife Therapeutics Inc., San Francisco, CA, USA

Josephine Kemna

1T-knife Therapeutics Inc., San Francisco, CA, USA